000 01223 a2200349 4500
005 20250515132048.0
264 0 _c20080902
008 200809s 0 0 eng d
022 _a1574-8863
024 7 _a10.2174/157488606775252593
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe las Cuevas, Carlos
245 0 0 _aSafety of selective serotonin reuptake inhibitors in pregnancy.
_h[electronic resource]
260 _bCurrent drug safety
_cJan 2006
300 _a17-24 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aMental Disorders
_xdrug therapy
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdrug therapy
650 0 4 _aPrenatal Exposure Delayed Effects
_xepidemiology
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
650 0 4 _aTeratogens
_xtoxicity
700 1 _aSanz, Emilio J
773 0 _tCurrent drug safety
_gvol. 1
_gno. 1
_gp. 17-24
856 4 0 _uhttps://doi.org/10.2174/157488606775252593
_zAvailable from publisher's website
999 _c18165189
_d18165189